Clinical Trials Directory

Trials / Completed

CompletedNCT05812742

Chasing Biomarkers in Post-concussion Syndrome

Neurofilament Light Chain, Inflammatory Markers, Calcitonin Gene-related Peptide, and Kynurenine Metabolites in Patients With Severe Post-concussive Symptoms

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
86 (actual)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The goal of this study was to investigate the biomarkers, neurofilament light chain, inflammatory markers, calcitonin-gene-related peptide, and metabolites from the kynurenine pathway in patients with severe post-concussive symptoms. The main question it aimed to answer was: * Are the biomarker concentrations significantly changed in patients with severe post-concussive symptoms compared to healthy individuals? * Do the biomarker concentrations change at follow-up? Participants were recruited from a recently published randomized controlled trial (Clinicaltrials.gov no. NCT02337101 / PMID: 31891145 ). The biomarker concentrations were compared to a healthy control group recruited from the Blood Bank at Aarhus University Hospital in 2022.

Detailed description

In the previously published RCT-study (PMID: 31891145), 86 participants with severe post-concussive symptoms provided blood samples at baseline (4 months after the concussion). Severe post-concussive symptoms were defined as having a Rivermead Post Concussion Questionnaire \>20. Around 7 months later, a follow-up blood sample was obtained from 54 participants. These blood samples were used to investigate blood biomarkers for the condition.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEarly intervention programmeFor more information, please go to the original registration of the RCT-study (NCT02337101) or the published article (PMID: 31891145).
BEHAVIORALEnhanced usual careFor more information, please go to the original registration of the RCT-study (NCT02337101) or the published article (PMID: 31891145).

Timeline

Start date
2015-03-01
Primary completion
2023-07-01
Completion
2023-07-01
First posted
2023-04-14
Last updated
2024-04-16

Source: ClinicalTrials.gov record NCT05812742. Inclusion in this directory is not an endorsement.